Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COV™ (casirivimab with imdevimab) Significantly Reduced Progression to Symptomatic COVID-19 ...Middle East

TARRYTOWN, N.Y., April 12, 2021 /PRNewswire/ -- Second Phase 3 trial undertaken in collaboration with NIAID to announce results today, both using subcutaneous administration of REGEN-COV in asymptomatic individuals without prior COVID-19 infection Regeneron Pharmaceuticals, Inc. (NASDAQ:...

Hence then, the article about phase 3 treatment trial in recently infected asymptomatic patients showed regen cov casirivimab with imdevimab significantly reduced progression to symptomatic covid 19 was published today ( Monday 12/04/2021 - 09:17 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COV™ (casirivimab with imdevimab) Significantly Reduced Progression to Symptomatic COVID-19 )

Also on site :

• Assassinations unleashed under Trump haunt Iran war endgame
• Disney's New 'Moana' Remake Opens With $4.5 Million — But Faces a $250 Million Problem
• Ro Khanna Calls for Charges After Israeli Settlers Detain Him in West Bank